Implantable Cardiac Monitors Market Increase in Awareness about Devices and Treatment Options for Cardiac Disorders Will Create Lucrative Opportunities for the Key Players in This Market

The Implantable Cardiac Monitors Market is projected to grow at a CAGR of 7.4% from 2017 to 2023 and reach $ 678.3 million by 2023. Heart arrhythmia marking almost half of market share in 2016.

An implantable cardiac monitor helps doctors assess the patient's health in relation to cardiac rhythm. This device aids in the treatment of heart patients, so that the patient has a working heart. It is used to monitor serious heart conditions such as heart attack, atrial fibrillation, and recent signs of heart attack. Due to the increased use of advanced batteries with durable battery life, the implantable loop recorder or heart monitor can be used to continuously monitor the patient for almost two to three years. This is ideal for patients requiring long-term continuous monitoring.

Technological advances in heart monitoring devices, awareness of patient awareness of heart disease monitoring and heart disease management, and high unmet medical needs are expected to drive market growth in developing and developing countries around the world. However, limited insurance coverage, increased device costs and drug preference for treatment devices are expected to curb market growth. On the contrary, the existence of favorable government initiatives and the contribution of independent organizations are expected to provide some opportunities for market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4517

The report provides a comprehensive analysis of the key players operating in the global implantable cardiac monitors market such as
• Abbott Laboratories
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Edwart
• General Electric Company
• Koninklijke Philips N.V.
• LivaNova PLC
• Medtronic plc
• Nihon Kohden Corporation
• Phoenix Heart Center

The other players of the global implantable cardiac monitors market include Astellas Pharma, Inc., Sigma-Aldrich Corporation, Agilent Technologies, Inc., ReliantHeart Inc., Abiomed, Inc., Basilea Pharmaceutical Ltd., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.

Atrial fibrillation accounts for approximately one-third of the total implantable cardiac monitor market in 2016 and is expected to remain in place throughout the forecast period.

The hospitals sector accounted for about two-thirds of the market share in 2016 and are expected to remain in force during the forecast period. This is due to the use of cardio monitoring devices in hospitals for acute care, non-acute care and non-treatment purposes.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/4517

Key Findings of the Implantable Cardiac Monitors Market:
• The epilepsy & unexplained falls are anticipated to grow at a steady rate during the analysis period.
• U.S. was the major shareholder in the North American implantable cardiac monitors market, accounting for the highest share in 2016.
• China occupied one-sixth share of the total Asia-Pacific implantable cardiac monitors market in 2016, and is expected to register a CAGR of 9.4% from 2017 to 2023.
• The cardiac centers & clinics segment witnessed the highest growth, and is anticipated to grow at a CAGR of 8.4% from 2017 to 2023.
• In terms of volume, the global implantable cardiac monitors market is forecasted to reach 261 thousand units by 2023 at a CAGR of 10.3% from 2017-2023.

In 2016, Asia-Pacific and LAMEA collectively accounted for nearly one-fifth share of the market, and are expected to continue this trend throughout the forecast period. Increase in awareness regarding cardiac monitoring; availability of cardiac monitors specifically in China, India, and the other developing economies and surge in prevalence of the cardiac diseases drive the market growth. Moreover, the massive target population and growth in economy catering to the establishment of healthcare facilities boost the growth of the market.

Access Full Summery @ https://www.alliedmarketresearch.com/implantable-cardiac-monitors-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.